Yale Medicine

Yale School of Medicine is highlighting advances in CAR-T therapy, a treatment that engineers a patient's immune cells to fight disease. Originally developed for blood cancers, the approach is now being adapted and studied for autoimmune conditions, marking a significant expansion of its potential use in medicine.

Yale Medicine reports that recent advances in treating head and neck cancer are leading to better patient outcomes. The overview highlights progress in therapies for these cancers, which affect the throat, mouth, voice box and surrounding areas. The message underscores growing optimism among clinicians about improved survival and quality of life, though the report does not detail specific new treatments or clinical trial results.